LLY compared with TXMD: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

TXMDTherapeuticsMD, Inc.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

TXMDTherapeuticsMD, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

LLYELI Lilly & Co

1,417.89▲+0.60%· post 1,418.53· delayed

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

TXMDTherapeuticsMD, Inc.

1.76▼−1.12%· post 1.81· delayed

After hoursNov 4 '26delayed

Mkt cap$20.7MRevenue$869,000Q2 FY26Revenue$3MFY25

Compare

After hoursNov 4 '26delayed

LLYELI Lilly & Co

TXMDTherapeuticsMD, Inc.

1,417.89▲+0.60%post 1,418.53delayed

Price

1.76▼−1.12%post 1.81delayed

$1.3T

Mkt cap

$20.7M

Q3 FY26$24.4B

Revenue

$869,000Q2 FY26

FY25$65.2B

Revenue

$3MFY25

LLY1,417.89▲+0.60%vsTXMD1.76▼−1.12%After hoursNov 4 '26delayed

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

TXMD: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

25 more · LLY chain ›

Shared 0

No disclosed counterparties: TXMD.

Only TXMD 0

None

Role chip = supplier or customerSource: SEC EDGAR

Price

rebased to 0%

LLY, solidTXMD, dashed